Journal of the American College of Nutrition, Vol 9, Issue 1 2-12, Copyright © 1990 by American College of Nutrition

CLINICAL TRIAL

Action of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjects

L. Cynober, C. Coudray-Lucas, J. P. de Bandt, J. Guechot, C. Aussel, M. Salvucci and J. Giboudeau
Laboratoire de Biochimie A, Hopital Saint Antoine, Paris, France.

Ornithine alpha-ketoglutarate (OKG) has been useful as an adjuvant of enteral and parenteral nutrition. However, its metabolism and mechanism of action remain unclear although it is known that alpha-ketoglutarate (alpha KG) and ornithine (ORN) follow, in part, common metabolic pathways. Six fasting healthy male subjects underwent three separate oral load tests: (i) they received 10 g of OKG (i.e., 3.6 g of alpha KG and 6.4 g of ORN); (ii) 6.4 g of ORN as ornithine hydrochloride, and (iii) 3.6 g of alpha KG as calcium alpha-ketoglutarate. Blood was drawn 15 times over a five-hour period for measurements of plasma amino acids, alpha KG, insulin, and glucagon. After OKG and ORN administration, plasma ORN peaked at 60-75 min (494 +/- 91 and 541 +/- 85 mumol/L). The increase in plasma alpha KG was very small. OKG, alpha KG, and ORN all increased glutamate concentrations at 60 min (mean: +43%, +68%, +68%, respectively, p less than 0.05 compared to basal values). However, only OKG increased proline and arginine levels at 60 min (mean: +35%, p less than 0.01 and mean: +41%, p less than 0.05). Furthermore, glutamate, proline, and arginine concentrations correlated linearly with ornithine levels at 60 min. Finally, OKG increased insulinemia and glucagonemia (mean: +24% at 15 min, p less than 0.05 and +30% at 60 min, p less than 0.01, respectively). These data provide evidence that the combination of ORN and alpha KG modifies amino acid metabolism in a way which is not observed when they are administered separately. In addition, the OKG-mediated increase in insulin levels probably does not appear to result from a direct action of ORN on pancreatic secretion.

This article has been cited by other articles:

				L. Cynober Ornithine {alpha}-Ketoglutarate as a Potent Precursor of Arginine and Nitric Oxide: A New Job for an Old Friend J. Nutr., October 1, 2004; 134(10): 2858S - 2862S. [Abstract] [Full Text] [PDF]

				M. Bruce, D. Constantin-Teodosiu, P. L. Greenhaff, L. H. Boobis, C. Williams, and J. L. Bowtell Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E669 - E675. [Abstract] [Full Text] [PDF]

				J.-P. De Bandt, C. Coudray-Lucas, N. Lioret, S. K. Lim, R. Saizy, J. Giboudeau, and L. Cynober A Randomized Controlled Trial of the Influence of the Mode of Enteral Ornithine alpha -Ketoglutarate Administration in Burn Patients J. Nutr., March 1, 1998; 128(3): 563 - 569. [Abstract] [Full Text]